Cholangiocellular Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-08-28
Clinical Trial Update: A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors [Phase 2]
Phase 2 trial updating on trastuzumab emtansine in HER2-overexpressing solid tumors has completed; results posted in 2019.